Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.

View in: PubMed

subject areas

Animals
Animals
Biomarkers, Tumor
Biomarkers, Tumor
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Cell Line, Tumor
Cell Line, Tumor
Cell Proliferation
Cell Proliferation
Databases, Genetic
Databases, Genetic
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Gene Knockdown Techniques
Genetic Therapy
Genetic Therapy
Humans
Humans
Intracellular Signaling Peptides and Proteins
Intracellular Signaling Peptides and Proteins
Liver Cirrhosis
Liver Cirrhosis
Liver Neoplasms
Liver Neoplasms
Mice, Nude
Mice, Nude
MicroRNAs
MicroRNAs
Neoplastic Stem Cells
Neoplastic Stem Cells
Phenotype
Phenotype
Retrospective Studies
Retrospective Studies
RNA Interference
RNA Interference
RNAi Therapeutics
RNAi Therapeutics
Signal Transduction
Signal Transduction
Time Factors
Time Factors
Transcription Factors
Transcription Factors
Transfection
Transfection
Tumor Burden
Tumor Burden
Up-Regulation
Up-Regulation
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays

authors with profiles

Naushad Ali
Courtney Wayne Houchen
Dongfeng Qu
Javid Fazili
Kai Ding
Mohammad Farouq Madhoun
Randal Joseph May